Is Oncolytics Biotech Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: ONCY) stock is to Strong Buy ONCY stock.
Out of 3 analysts, 2 (66.67%) are recommending ONCY as a Strong Buy, 1 (33.33%) are recommending ONCY as a Buy, 0 (0%) are recommending ONCY as a Hold, 0 (0%) are recommending ONCY as a Sell, and 0 (0%) are recommending ONCY as a Strong Sell.
What is ONCY's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: ONCY) forecast ROE is N/A, which is considered weak.
What is ONCY's Price Target?
According to 3 Wall Street analysts that have issued a 1 year ONCY price target, the average ONCY price target is $9.67, with the highest ONCY stock price forecast at $15.00 and the lowest ONCY stock price forecast at $5.00.
On average, Wall Street analysts predict that Oncolytics Biotech's share price could reach $9.67 by May 26, 2024. The average Oncolytics Biotech stock price prediction forecasts a potential upside of 462.03% from the current ONCY share price of $1.72.
What is ONCY's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: ONCY) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.